+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Therapeutic Plasma Exchange Market by Application, Procedure Type, Product Type, End User - Global Forecast to 2030- Product Image
Therapeutic Plasma Exchange Market by Application, Procedure Type, Product Type, End User - Global Forecast to 2030- Product Image
Sale

Therapeutic Plasma Exchange Market by Application, Procedure Type, Product Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5147996
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Therapeutic Plasma Exchange Market grew from USD 878.53 million in 2024 to USD 964.89 million in 2025. It is expected to continue growing at a CAGR of 9.65%, reaching USD 1.52 billion by 2030.

Setting the Stage for Plasma Exchange Advancements

Therapeutic plasma exchange has evolved into a cornerstone of treatment for a variety of critical disorders, forging a path toward improved patient outcomes and novel clinical approaches. In recent years, advancements in device technologies and procedural protocols have transformed a once niche therapy into a mainstream intervention. This introduction lays the foundation for appreciating the intricate dynamics that define the current market environment. From the refinement of centrifugation and membrane separation techniques to the diversification of applications across autoimmune, hematological, neurological, and renal disorders, the plasma exchange landscape is marked by rapid technological innovation and deepening clinical acceptance.

Moreover, intersecting trends in healthcare policy, reimbursement frameworks, and regulatory pathways continue to shape the accessibility and adoption of plasma exchange therapies. As decision-makers grapple with balancing cost pressures against the imperative to deliver high-quality care, an understanding of the therapeutic plasma exchange market’s multifaceted drivers becomes indispensable. This opening section sets the stage for a thorough exploration of market forces, emerging challenges, and opportunities for stakeholders seeking to navigate a dynamic and rapidly maturing segment of the healthcare industry.

Redefining Treatment Paradigms Through Technology and Evidence

The therapeutic plasma exchange landscape is undergoing transformative shifts propelled by convergence of innovation, clinical data, and patient demand. Advances in membrane materials and disposable consumables have dramatically improved procedure safety and efficiency, reducing extracorporeal volume requirements and shortening turnaround times. This has led to higher throughput in hospital and specialized center settings, fostering broader adoption among clinicians.

At the same time, expanding evidence in neurological applications-particularly chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome, multiple sclerosis, and myasthenia gravis-has solidified plasma exchange as a first-line therapy for certain patient cohorts. Simultaneously, its indication spectrum in autoimmune and hematological disorders continues to grow, driven by an uptick in real-world evidence and publication of robust clinical guidelines. The cumulative effect of these developments has been a redefinition of plasma exchange from a last-resort intervention to a proactive treatment modality integrated into standard care pathways.

These transformative shifts extend to the procedural landscape as well, with innovations in device connectivity and data analytics enabling predictive maintenance and workflow optimization. Integration of digital platforms now allows practitioners to monitor procedural metrics in real time, improving safety and enabling more personalized treatment regimens. As the market progresses, these technological and clinical breakthroughs will continue to recalibrate competitive dynamics and expand the horizons of therapeutic plasma exchange.

Navigating the Ripple Effects of US Tariffs

In 2025, the introduction of new tariffs on medical consumables and devices is projected to influence the cost structure of therapeutic plasma exchange solutions across the United States. These cumulative tariffs are expected to impact the procurement strategies of hospitals, clinics, and specialized centers, prompting many providers to reevaluate supplier contracts and explore alternative sourcing options. While domestically manufactured devices may see a competitive advantage in price-sensitive environments, reliance on imported replacement fluids and tubing sets may face pricing pressures that ripple through hospital budgets.

This tariff environment could slow down the adoption rate of high-end membrane TPE systems, shifting attention toward centrifugation-based devices where local manufacturing can offset additional duties. Moreover, the tariffs on replacement fluids, especially fresh frozen plasma and certain albumin formulations, might drive a preference for colloids and crystalloids when clinically appropriate. As a result, providers and manufacturers alike will need to collaborate on cost-containment programs, such as value-based purchasing agreements and bundled payment models, to mitigate the impact of these new duties while maintaining patient access to life-saving therapies.

Strategic responses will likely include regional sourcing partnerships and investment in domestic supply chains. Regulatory bodies and industry associations will play a critical role in advocating for tariff exemptions or reductions on essential medical products. In parallel, forward-thinking companies may accelerate investment in research and development of locally sourced consumables to fortify resilience against future trade disruptions.

Uncovering High-Value Segments Driving Growth

Segment insights reveal nuanced opportunities within the plasma exchange market. When viewed through the lens of application, therapy is most prevalent in autoimmune disorders, hematological conditions, neurological indications, and renal failure. Among these, neurological applications stand out, particularly in treating chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome, multiple sclerosis, and myasthenia gravis, signaling high unmet need and growing clinical acceptance.

Turning to procedural dynamics, two distinct streams emerge: centrifugation-based and membrane-based plasma exchange. Centrifugation TPE systems, with established track records, offer robustness and ease of operation, while membrane TPE devices promise reduced extracorporeal volumes and enhanced safety profiles. The choice between these modalities often hinges on institutional preference, patient-specific risk factors, and reimbursement considerations.

In terms of product portfolio, consumables, devices, and kits form the backbone of market revenue streams. Within the consumables category, anticoagulants, replacement fluids, and tubing sets command significant share. Replacement fluids themselves are diversified into albumin, colloids, crystalloids, and fresh frozen plasma, each presenting unique cost and clinical application profiles. Consumable optimization remains a critical focus for providers aiming to balance efficacy with affordability.

Finally, end users spanning clinics, hospitals, and specialized plasma exchange centers each exhibit distinct purchasing behaviors and volume requirements. Clinics often prioritize cost-effective consumable bundles and streamlined devices, hospitals balance high volume needs with stringent safety standards, and specialized centers invest in premium devices that maximize throughput and patient comfort.

Regional Dynamics Shaping Market Opportunities

A regional perspective underscores divergent market trajectories across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, established reimbursement frameworks and a high prevalence of autoimmune and neurological disorders create a fertile environment for advanced devices and premium consumables. Providers in North America often lead in adopting membrane-based systems and integrating digital monitoring tools.

In contrast, Europe Middle East & Africa presents a heterogeneous market landscape. Western Europe’s mature healthcare systems focus on cost containment and evidence-based adoption, driving interest in bundled procurement strategies. Meanwhile, emerging economies in the Middle East and Africa are prioritizing capacity-building initiatives, seeking affordable centrifugation devices and domestically sourced replacement fluids to expand access to life-saving therapies.

Asia-Pacific stands out as a rapid-growth region, fueled by increasing healthcare expenditure, rising awareness of plasma exchange benefits, and expansion of specialized treatment centers. Local manufacturing hubs in countries such as China and India are scaling production of consumables, offering cost advantages that are reshaping procurement patterns. At the same time, collaboration between global device leaders and regional distributors is facilitating technology transfer and training programs, accelerating market penetration.

Strategic Moves from Leading Market Players

Key industry players are intensifying their focus on product differentiation and strategic partnerships to secure market share. Leading device manufacturers are expanding their portfolios through targeted acquisitions of innovative membrane technology firms, while bolstering their consumable offerings with next-generation anticoagulants and tubing materials. Companies with robust R&D pipelines are also forging collaborations with academic institutions and clinical centers to generate compelling real-world evidence in emerging neurological and renal indications.

In parallel, some firms are investing in digital platforms that deliver predictive maintenance alerts and data analytics, enhancing device uptime and delivering actionable insights for clinicians. Others are establishing regional manufacturing facilities to mitigate tariff impacts and strengthen supply chain resilience. A noticeable trend is the rise of contract manufacturing partnerships in Asia-Pacific, where global brands leverage local expertise to optimize production costs and accelerate time-to-market for new consumables.

Actionable Paths to Enhance Market Leadership

To capitalize on evolving market dynamics, industry leaders should prioritize an integrated value proposition that aligns product innovation with cost optimization. Engaging payers early to structure outcome-based or bundled payment models can secure favorable reimbursement and accelerate adoption of advanced membrane-based systems. Additionally, collaborations with regional distributors and local manufacturers will be critical for navigating tariff-related cost pressures and ensuring consistent supply of high-quality consumables.

Manufacturers are advised to invest in training and education programs for clinicians and support staff, positioning themselves as partners in improving patient outcomes. Offering turnkey digital solutions that streamline procedural workflows and enhance data-driven decision-making can become a differentiator in a crowded market. Finally, maintaining a flexible manufacturing footprint, supported by dual sourcing strategies, will enable rapid adaptation to fluctuating trade policies and minimize disruption to end users.

Robust Multi-Source Research Ensuring Insight Reliability

This report synthesizes insights from an extensive review of public and proprietary sources, including regulatory filings, clinical studies, and industry publications. Interviews with key opinion leaders in neurology, hematology, nephrology, and transfusion medicine were conducted to validate market trends and cross-verify primary data findings. Proprietary databases tracking device approvals, consumable registrations, and procedural volumes were leveraged to uncover historical patterns and identify emerging growth drivers.

Secondary research involved a rigorous examination of trade association reports, government tariffs schedules, and healthcare expenditure data to contextualize the impact of regulatory and economic factors. Quantitative analysis was supported by triangulation between manufacturer sales data, hospital procurement records, and import-export statistics. All findings were reviewed by an internal team of healthcare economists and domain experts to ensure methodological robustness and minimize bias.

Synthesis of Market Drivers and Strategic Imperatives

In conclusion, the therapeutic plasma exchange market stands at an inflection point marked by technological breakthroughs, shifting trade policies, and evolving clinical paradigms. As membrane-based systems gain traction and digital integration becomes table stakes, providers and manufacturers must navigate complex segmentation dynamics and regional nuances. The impending tariff environment in the United States underscores the need for agile sourcing and collaborative value-based strategies.

By understanding high-value applications in neurological, autoimmune, hematological, and renal domains, and aligning product portfolios accordingly, stakeholders can unlock new growth avenues. Regional disparities offer both challenges and opportunities, from mature markets in North America and Western Europe to high-growth corridors in Asia-Pacific and capacity-building regions in the Middle East and Africa. Forward-looking companies that deploy holistic approaches-melding innovation, cost management, and strategic partnerships-will be best positioned to lead the market into its next phase of expansion.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Autoimmune Disorders
    • Hematological Disorders
    • Neurological Disorders
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • Guillain-Barré Syndrome
      • Multiple Sclerosis
      • Myasthenia Gravis
    • Renal Disorders
  • Procedure Type
    • Centrifugation TPE
    • Membrane TPE
  • Product Type
    • Consumables
      • Anticoagulants
      • Replacement Fluids
        • Albumin
        • Colloids
        • Crystalloids
        • Fresh Frozen Plasma
      • Tubing Sets
    • Devices
    • Kits
  • End User
    • Clinics
    • Hospitals
    • Specialized Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Terumo Corporation
  • Haemonetics Corporation
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Asahi Kasei Medical Co., Ltd.
  • Kaneka Corporation
  • Grifols, S.A.
  • MacoPharma S.A.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Therapeutic Plasma Exchange Market, by Application
8.1. Introduction
8.2. Autoimmune Disorders
8.3. Hematological Disorders
8.4. Neurological Disorders
8.4.1. Chronic Inflammatory Demyelinating Polyneuropathy
8.4.2. Guillain-Barré Syndrome
8.4.3. Multiple Sclerosis
8.4.4. Myasthenia Gravis
8.5. Renal Disorders
9. Therapeutic Plasma Exchange Market, by Procedure Type
9.1. Introduction
9.2. Centrifugation TPE
9.3. Membrane TPE
10. Therapeutic Plasma Exchange Market, by Product Type
10.1. Introduction
10.2. Consumables
10.2.1. Anticoagulants
10.2.2. Replacement Fluids
10.2.2.1. Albumin
10.2.2.2. Colloids
10.2.2.3. Crystalloids
10.2.2.4. Fresh Frozen Plasma
10.2.3. Tubing Sets
10.3. Devices
10.4. Kits
11. Therapeutic Plasma Exchange Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
11.4. Specialized Centers
12. Americas Therapeutic Plasma Exchange Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Therapeutic Plasma Exchange Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Therapeutic Plasma Exchange Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Baxter International Inc.
15.3.2. Fresenius Kabi AG
15.3.3. Terumo Corporation
15.3.4. Haemonetics Corporation
15.3.5. B. Braun Melsungen AG
15.3.6. Nipro Corporation
15.3.7. Asahi Kasei Medical Co., Ltd.
15.3.8. Kaneka Corporation
15.3.9. Grifols, S.A.
15.3.10. MacoPharma S.A.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. THERAPEUTIC PLASMA EXCHANGE MARKET MULTI-CURRENCY
FIGURE 2. THERAPEUTIC PLASMA EXCHANGE MARKET MULTI-LANGUAGE
FIGURE 3. THERAPEUTIC PLASMA EXCHANGE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. THERAPEUTIC PLASMA EXCHANGE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. THERAPEUTIC PLASMA EXCHANGE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. THERAPEUTIC PLASMA EXCHANGE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION TPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE TPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COLLOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CRYSTALLOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TUBING SETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 54. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 57. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 58. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 64. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 97. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 100. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 101. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 104. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 105. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 107. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 108. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 118. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 119. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 121. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 122. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 125. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 128. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 129. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 153. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 156. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 157. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 167. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 168. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 170. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 171. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 174. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 175. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 177. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 178. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 195. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 196. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 198. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 199. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 202. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 203. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 205. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 206. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 216. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 217. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 219. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 220. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 223. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 224. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 226. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 227. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 243. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 245. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 246. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 248. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 249. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 252. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 253. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 255. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 256. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 259. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 260. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 262. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 263. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 287. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 288. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 290. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 291. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Therapeutic Plasma Exchange market report include:
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Terumo Corporation
  • Haemonetics Corporation
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Asahi Kasei Medical Co., Ltd.
  • Kaneka Corporation
  • Grifols, S.A.
  • MacoPharma S.A.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 964.89 Million
Forecasted Market Value ( USD ) by 2030 $ 1520 Million
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Therapeutic Plasma Exchange - Global Strategic Business Report - Product Image

Therapeutic Plasma Exchange - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Therapeutic Plasma Exchange Market Report 2025 - Product Image

Therapeutic Plasma Exchange Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Therapeutic Plasma Exchange Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Therapeutic Plasma Exchange Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 93 Pages
  • Global
From
Plasma Fractionation Market by Product Type, Method of Fractionation, Application, End-User - Global Forecast to 2030 - Product Image

Plasma Fractionation Market by Product Type, Method of Fractionation, Application, End-User - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Plasma Therapy Market by Technology, Therapeutic Area, End User, Source, Application, Distribution Channel - Global Forecast to 2030 - Product Image

Plasma Therapy Market by Technology, Therapeutic Area, End User, Source, Application, Distribution Channel - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From

About the Therapeutic Plasma Exchange Market

Therapeutic Plasma Exchange (TPE) is a process used in blood banking to treat a variety of medical conditions. It involves the removal of plasma from a patient's blood and replacing it with donor plasma or a plasma substitute. The process is used to treat conditions such as autoimmune diseases, thrombotic thrombocytopenic purpura, and hemolytic anemia. It is also used to remove antibodies and other substances from the blood that can cause adverse reactions. TPE is a specialized procedure that requires specialized equipment and trained personnel. It is typically performed in a hospital or clinic setting. The process is usually done in a series of treatments, with the number of treatments depending on the condition being treated. The TPE market is a growing segment of the blood banking industry. It is a highly specialized field that requires specialized equipment and personnel. Companies in the market include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, and Asahi Kasei Medical. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.